Morgan Stanley’s Curis CRIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $139K | Buy |
12,712
+12,709
| +423,633% | +$237K | ﹤0.01% | 6026 |
|
|
2025
Q4 | $56 | Sell |
3
-39
| -93% | -$1.05K | ﹤0.01% | 7810 |
|
|
2025
Q3 | $1.4K | Hold |
42
| – | – | ﹤0.01% | 7358 |
|
|
2025
Q2 | $1.96K | Hold |
42
| – | – | ﹤0.01% | 7226 |
|
|
2025
Q1 | $1.77K | Sell |
42
-1
| -2% | -$62 | ﹤0.01% | 7195 |
|
|
2024
Q4 | $2.61K | Hold |
43
| – | – | ﹤0.01% | 7149 |
|
|
2024
Q3 | $4.65K | Sell |
43
-1
| -2% | -$112 | ﹤0.01% | 6930 |
|
|
2024
Q2 | $6.13K | Hold |
44
| – | – | ﹤0.01% | 6803 |
|
|
2024
Q1 | $9.66K | Sell |
44
-45
| -51% | -$9.68K | ﹤0.01% | 6724 |
|
|
2023
Q4 | $22.8K | Buy |
89
+44
| +98% | +$7.02K | ﹤0.01% | 6617 |
|
|
2023
Q3 | $5.89K | Sell |
45
-37
| -45% | -$9.52K | ﹤0.01% | 6875 |
|
|
2023
Q2 | $27.1K | Buy |
82
+1
| +1% | +$325 | ﹤0.01% | 6451 |
|
|
2023
Q1 | $19.4K | Sell |
81
-494
| -86% | -$130K | ﹤0.01% | 6641 |
|
|
2022
Q4 | $127K | Sell |
575
-21
| -4% | -$6.16K | ﹤0.01% | 5878 |
|
|
2022
Q3 | $167K | Buy |
596
+218
| +58% | +$87.9K | ﹤0.01% | 5811 |
|
|
2022
Q2 | $149K | Sell |
378
-5,313
| -93% | -$2.22M | ﹤0.01% | 6040 |
|
|
2022
Q1 | $5.42M | Buy |
5,691
+4,901
| +620% | +$6.26M | ﹤0.01% | 3605 |
|
|
2021
Q4 | $1.5M | Sell |
790
-154
| -16% | -$366K | ﹤0.01% | 4784 |
|
|
2021
Q3 | $2.95M | Buy |
944
+383
| +68% | +$1.2M | ﹤0.01% | 4249 |
|
|
2021
Q2 | $1.81M | Buy |
561
+533
| +1,904% | +$2.41M | ﹤0.01% | 4706 |
|
|
2021
Q1 | $126K | Sell |
28
-26
| -48% | -$109K | ﹤0.01% | 5890 |
|
|
2020
Q4 | $178K | Hold |
54
| – | – | ﹤0.01% | 5647 |
|
|
2020
Q3 | $25K | Sell |
54
-1
| -2% | -$472 | ﹤0.01% | 5973 |
|
|
2020
Q2 | $26K | Sell |
55
-1
| -2% | -$369 | ﹤0.01% | 5932 |
|
|
2020
Q1 | $16K | Buy |
56
+8
| +17% | +$4.25K | ﹤0.01% | 5882 |
|
|
2019
Q4 | $33K | Sell |
48
-3
| -6% | -$2.18K | ﹤0.01% | 5969 |
|
|
2019
Q3 | $46K | Buy |
51
+2
| +4% | +$1.69K | ﹤0.01% | 5749 |
|
|
2019
Q2 | $37K | Buy |
49
+30
| +158% | +$21K | ﹤0.01% | 5720 |
|
|
2019
Q1 | $15K | Sell |
19
-81
| -81% | -$38.8K | ﹤0.01% | 6092 |
|
|
2018
Q4 | $27K | Sell |
100
-7
| -7% | -$3.83K | ﹤0.01% | 5946 |
|
|
2018
Q3 | $76K | Sell |
107
-406
| -79% | -$265K | ﹤0.01% | 5768 |
|
|
2018
Q2 | $355K | Buy |
513
+326
| +174% | +$334K | ﹤0.01% | 5298 |
|
|
2018
Q1 | $244K | Sell |
187
-53
| -22% | -$69.4K | ﹤0.01% | 5386 |
|
|
2017
Q4 | $336K | Buy |
240
+120
| +100% | +$282K | ﹤0.01% | 5186 |
|
|
2017
Q3 | $358K | Buy |
120
+8
| +7% | +$29.6K | ﹤0.01% | 5065 |
|
|
2017
Q2 | $424K | Sell |
112
-5
| -4% | -$20.9K | ﹤0.01% | 4910 |
|
|
2017
Q1 | $648K | Sell |
117
-89
| -43% | -$495K | ﹤0.01% | 4679 |
|
|
2016
Q4 | $1.27M | Buy |
206
+151
| +275% | +$907K | ﹤0.01% | 4287 |
|
|
2016
Q3 | $290K | Sell |
55
-9
| -14% | -$33K | ﹤0.01% | 4822 |
|
|
2016
Q2 | $198K | Buy |
64
+9
| +16% | +$32.1K | ﹤0.01% | 4942 |
|
|
2016
Q1 | $176K | Sell |
55
-11
| -17% | -$37K | ﹤0.01% | 5050 |
|
|
2015
Q4 | $383K | Buy |
66
+17
| +35% | +$83K | ﹤0.01% | 4714 |
|
|
2015
Q3 | $199K | Sell |
49
-2
| -4% | -$11.3K | ﹤0.01% | 5083 |
|
|
2015
Q2 | $340K | Sell |
51
-97
| -66% | -$583K | ﹤0.01% | 4956 |
|
|
2015
Q1 | $712K | Buy |
148
+107
| +261% | +$516K | ﹤0.01% | 4390 |
|
|
2014
Q4 | $122K | Sell |
41
-12
| -23% | -$31.5K | ﹤0.01% | 5469 |
|
|
2014
Q3 | $150K | Sell |
53
-57
| -52% | -$192K | ﹤0.01% | 5283 |
|
|
2014
Q2 | $408K | Buy |
110
+64
| +139% | +$261K | ﹤0.01% | 4733 |
|
|
2014
Q1 | $259K | Sell |
46
-38
| -45% | -$228K | ﹤0.01% | 4973 |
|
|
2013
Q4 | $473K | Buy |
84
+18
| +27% | +$123K | ﹤0.01% | 4484 |
|
|
2013
Q3 | $587K | Buy |
66
+24
| +57% | +$194K | ﹤0.01% | 4221 |
|
|
2013
Q2 | $270K | Buy |
+42
| New | +$297K | ﹤0.01% | 4662 |
|
Other funds holding CRIS
BL
SCM
NCM
SFM
CCC
DIG
VCM
MCM
Morgan Stanley's CRIS Position: Q1 2026 in Review
Morgan Stanley increased its Curis (CRIS) stake by 423,633% in Q1 2026, buying an estimated $237K and bringing the position to 12,712 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #6026.
Morgan Stanley first reported a position in CRIS in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.42M in Q1 2022. 39 funds tracked by Wall St. Rank hold CRIS as of Q1 2026.
- Morgan Stanley held 12,712 shares of Curis worth $139K as of Q1 2026.
- Morgan Stanley bought 12,709 Curis shares in Q1 2026, an estimated $237K.
- Curis made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6026 holding.
- Morgan Stanley first reported a position in Curis in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's Curis position peaked at $5.42M in Q1 2022.
- 39 funds tracked by Wall St. Rank held Curis as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.